<SEC-DOCUMENT>0001178913-22-001006.txt : 20220309
<SEC-HEADER>0001178913-22-001006.hdr.sgml : 20220309
<ACCEPTANCE-DATETIME>20220309060518
ACCESSION NUMBER:		0001178913-22-001006
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220309
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220309
DATE AS OF CHANGE:		20220309

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chemomab Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813676773
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38807
		FILM NUMBER:		22723846

	BUSINESS ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002
		BUSINESS PHONE:		972-77-331-0156

	MAIL ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anchiano Therapeutics Ltd.
		DATE OF NAME CHANGE:	20180906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>zk2227450.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:cmmb="http://chemomab.com/20220309" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Z-K Global
         Document created using EDGARfilings PROfile 8.1.0.0
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_c4648d413a80429490b83737684960a3" contextRef="c20220309to20220309" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_827b499388894d2983d2699b4fac3458" contextRef="c20220309to20220309">00-0000000</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_bb5eac91d82c47d694f161e9a8eda0ed" contextRef="c20220309to20220309">0001534248</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_7800ee96276548b596341b580ba682e4" contextRef="c20220309to20220309_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">NASDAQ</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_6d5d9dde38ce41a79ef18960f5e679b6" contextRef="c20220309to20220309_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">NASDAQ</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="cmmb-20220309.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20220309to20220309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-09</xbrli:startDate><xbrli:endDate>2022-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220309to20220309_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-09</xbrli:startDate><xbrli:endDate>2022-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220309to20220309_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-09</xbrli:startDate><xbrli:endDate>2022-03-09</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
    <div> <div><br /></div>

      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b> UNITED STATES</b></p>
      <p style="font: 14pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>WASHINGTON, D.C. 20549</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;&#160;</p>
      <p style="font: 14pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_1e8d67a5e319479a96041d8c4f7e3915" contextRef="c20220309to20220309">8-K</ix:nonNumeric></b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>CURRENT REPORT</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>Pursuant to Section&#160;13 or 15(d)</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>of the Securities Exchange Act of 1934</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_097c3bd6996d46e2bd4575c8433d9ffd" contextRef="c20220309to20220309" format="ixt:datemonthdayyearen">March 9, 2022</ix:nonNumeric></b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
      <p style="font: 16pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_54f7699f403b4b8da0f3061dbb621ab8" contextRef="c20220309to20220309">Chemomab Therapeutics Ltd.</ix:nonNumeric><br />
        </b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>(Exact name of Registrant as Specified in Its Charter)</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" border="0" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr style="vertical-align: top;">

    <td style="width: 33%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">State of <ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_ed7f83e55f0a4b08beddae26671ea988" contextRef="c20220309to20220309" format="ixt-sec:edgarprovcountryen">Israel</ix:nonNumeric></td>

    <td style="width: 33%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_23f534d54203453daaea000a94b759db" contextRef="c20220309to20220309">001-38807</ix:nonNumeric><br />
            </td>

    <td style="width: 33%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><span style="-sec-ix-hidden:Fact_827b499388894d2983d2699b4fac3458">81-3676773</span><br />
            </td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>(State or Other Jurisdiction</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>(Commission</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>(IRS Employer</b></td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>of Incorporation)</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>File Number)</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>Identification No.)</b></td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" border="0" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr>

    <td style="width: 50%; text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_e24b9d3f80794d4685c212a8f19bc425" contextRef="c20220309to20220309">Kiryat Atidim, Building 7</ix:nonNumeric></span><br />
            </td>

    <td style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_4fa2b9620e824a57b1f54dd90922a682" contextRef="c20220309to20220309">Tel Aviv</ix:nonNumeric>,
                <ix:nonNumeric name="dei:EntityAddressCountry" id="Fact_b9d79dd8c8ac402da729318d023d8bec" contextRef="c20220309to20220309" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></b></td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_7d3c117f227b4ad7b829a6bd78c06980" contextRef="c20220309to20220309">6158002</ix:nonNumeric><br />
              </b></td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b>(Address of principal executive offices)</b></td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b>(Zip Code)</b></td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;"><b>Registrant&#8217;s telephone number, including area code: +<ix:nonNumeric name="dei:CityAreaCode" id="Fact_056db533a90749b29f8b400205334538" contextRef="c20220309to20220309">972</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_a465d30b3ba54a55af9eec32f997a7b4" contextRef="c20220309to20220309">77-331-0156</ix:nonNumeric></b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;"><b>(Former name or former address, if changed since last report)</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr style="vertical-align: top;">

    <td style="width: 5%; text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_58591e2e1f2443529562a6b7d3838234" contextRef="c20220309to20220309" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: 95%; text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_34813f63dc0844ef81c013044741f24c" contextRef="c20220309to20220309" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_c93b00f1407c48d2abcfa1faa8eb2967" contextRef="c20220309to20220309" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_ee53ffb1d4404dd9bf8384d2237b75eb" contextRef="c20220309to20220309" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;"><b>Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" border="0" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr style="vertical-align: bottom;">

    <td style="width: 49%; text-align: center; white-space: nowrap; font-family: 'Times New Roman',Times,serif; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><b>Title of each class</b></td>

    <td style="width: 1%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 24%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><b>Trading<br />
                Symbol(s)</b></td>

    <td style="width: 1%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 25%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><b>Name of each <br />
                exchange<br />
                on&#160;which&#160;registered</b></td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 49%; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_b123c56576e3485d98bde4754511ff63" contextRef="c20220309to20220309_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share</ix:nonNumeric><br />
            </td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 24%; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_efc8b1a62843452ea835025b22e31abb" contextRef="c20220309to20220309_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">CMMB</ix:nonNumeric><br />
            </td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 25%; font-weight: bold;"><span style="-sec-ix-hidden:Fact_6d5d9dde38ce41a79ef18960f5e679b6">Nasdaq Capital Market</span><br />
            </td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 49%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 24%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 25%; font-weight: bold;">&#160;</td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 49%; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_adcba5d2ba7c41fa96ede1c9ee9b9160" contextRef="c20220309to20220309_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">Ordinary shares, no par value per share</ix:nonNumeric><br />
            </td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 24%; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_e57ed6f5b2144c9b95a26c319b8d02b2" contextRef="c20220309to20220309_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">N/A</ix:nonNumeric></td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 25%; font-weight: bold;"><span style="-sec-ix-hidden:Fact_7800ee96276548b596341b580ba682e4">Nasdaq Capital Market</span>*</td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">* Not for trading; only in connection with the registration of American Depositary Shares.</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule&#160;12b-2 of the
        Securities Exchange Act of 1934 (&#167;&#160;240.12b-2 of this chapter).</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">Emerging growth company&#160; <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_dd30d57e27ef4063b7ff9d2b9c5d7da4" contextRef="c20220309to20220309" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
        accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160; <ix:nonNumeric name="dei:EntityExTransitionPeriod" id="Fact_4060debb196f400b9b60e23eaa2c782f" contextRef="c20220309to20220309" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></p>
    </div>

    <div> <span style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><br />
      </span></div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--PROfilePageNumberReset%Num%2%- % -%-->
    <div style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> <br />
    </div>

    <div style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 100%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 2.02. Results of Operations and Financial Condition.</div>
            </td>

  </tr>


</table>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br />
        </div>

      </div>

      <div style="line-height: 1.25;">
        <div style="text-align: left; text-indent: 28.35pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On March 9, 2022, Chemomab Therapeutics Ltd. (the &#8220;Company&#8221;) issued a press release announcing its financial
          results for its fourth quarter and year ended December 31, 2021. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference.</div>

        <div style="line-height: 1.25">&#160;</div>

      </div>

      <div style="line-height: 1.25;">
        <div style="text-align: left; text-indent: 28.35pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The information contained herein and in the accompanying exhibit are &#8220;furnished&#8221; and shall not be deemed &#8220;filed&#8221;
          for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference in any filing under the Securities Act of
          1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.</div>

        <div style="line-height: 1.25">&#160;</div>

      </div>

      <div style="line-height: 1.25;">
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 9.01 Financial Statements and Exhibits.</div>

        <div style="line-height: 1.25">&#160;</div>

        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">(d) Exhibits</div>

        <div style="line-height: 1.25">&#160;</div>

      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 11.7%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit Number</div>
            </td>

    <td style="width: 1.16%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 87.14%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit Description</div>
            </td>

  </tr>

  <tr>

    <td style="width: 11.7%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="exhibit_99-1.htm">99.1</a></div>
            </td>

    <td style="width: 1.16%; vertical-align: top;"><br />
            </td>

    <td style="width: 87.14%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="exhibit_99-1.htm">Press release issued by
                  Chemomab Therapeutics Ltd. dated March 9, 2022</a></div>
            </td>

  </tr>

  <tr>

    <td style="width: 11.7%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">104</div>
            </td>

    <td style="width: 1.16%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 87.14%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
            </td>

  </tr>


</table>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">- 2 -</span></div>

          <div style="page-break-after: always;" class="DSPFPageBreak">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        </div>

        <div><br /></div>

        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

        <div style="line-height: 1.25">&#160;</div>

      </div>

      <div style="line-height: 1.25;">
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
          behalf by the undersigned hereunto duly authorized.</div>

        <div style="line-height: 1.25">&#160;</div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.56%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td colspan="2" style="width: 41.8%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">CHEMOMAB THERAPEUTICS LTD.</div>
            </td>

    <td style="width: 8.64%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.56%; vertical-align: middle;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 3.34%; vertical-align: middle;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 38.46%; vertical-align: middle;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 8.64%; vertical-align: middle;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.56%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Date: March 9, 2022</div>
            </td>

    <td style="width: 3.34%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">By:</div>
            </td>

    <td style="width: 38.46%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">/s/&#160;</span>Donald Marvin</div>
            </td>

    <td style="width: 8.64%; vertical-align: middle;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.56%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 3.34%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 38.46%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Name: Donald Marvin</div>
            </td>

    <td style="width: 8.64%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.56%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 3.34%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 38.46%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Title: Executive V.P., Chief Financial Officer and Chief Operating Officer</div>
            </td>

    <td style="width: 8.64%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

  </tr>


</table>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br />
        </div>

        <div style="line-height: 1.25;">
          <div style="text-align: center;" class="DSPFPageNumberArea"><span style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: normal; font-style: normal;" class="DSPFPageNumber">- 3 -</span></div>

        </div>

      </div>

    </div>

    <div>
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

  </div>

  <div><span style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> </span></div>

  <div style="text-align: center;" class="DSPFPageNumberArea"><br />
  </div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K Global
         Document created using EDGARfilings PROfile 8.1.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"> <u><font style="font-weight: bold;">Exhibit 99.1</font></u><br>
    </div>
    <div> <br>
    </div>
    <div>
      <div id="DSPFPageHeader">
        <div style="text-align: left; line-height: 1.25;"><img width="201" height="56" src="image00001.jpg"></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25; background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-style: italic; font-variant: normal; text-transform: none;">
        <div style="text-align: center; line-height: 1.25;">Chemomab Therapeutics Announces Fourth Quarter and Year End 2021 Financial </div>
        <div style="text-align: center; line-height: 1.25;">Results and Provides a Corporate Update</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#9472;Company Announces Revisions Intended to Optimize CM-101 Clinical Development Program </div>
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">and Produce More Informative Data, More Rapidly and Efficiently; Changes Also Expected to </div>
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Extend Cash Runway through End of 2023&#9472;</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#9472;Company to Host Conference Call for Investors Today, March 9 at 8:00 am EST<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#9472;</font></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">TEL AVIV, Israel, March 9, 2022 </font>--
        <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Chemomab Therapeutics, Ltd</u></font>. (<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Nasdaq: CMMB), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need</font>, today announced
        financial and operating results for the fourth quarter and year ended December 31, 2021, and provided a corporate update.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2021&#160; Highlights:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zf0bd3d1a4eb9490eb647733070dd478c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In February, announced positive results from a Phase 1b trial in patients with non-alcoholic fatty liver disease. CM-101 appeared safe and well tolerated upon
                multiple administrations, with evidence for dose dependent target engagement and positive changes in fibrotic biomarkers.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zb7d6f68f72e84f0bbff21bf9cf8c0760" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In March, completed a merger transaction, listed the company&#8217;s ADS&#8217;s on Nasdaq and closed a $45.5M PIPE financing.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z5c149859a412442688a147a71190ea7a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In April, dosed the first patient in a CM-101 Phase 2 liver fibrosis biomarker and subcutaneous formulation study.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zc67c0d734fde41278024c2aefc72b922" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In June, expanded partnership with AGC Biologics for final optimization and production of GMP manufacturing batches of CM-101.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z619313bbf8f341f193fb1a803026a98f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In September, Dale Pfost, PhD, joined the company as chief executive officer. Chemomab co-founder, former CEO and chief scientific officer Adi Mor, PhD, continues as
                CSO and a director.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="za23f22c0751446c885596225d2a7c7eb" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In September, announced a collaboration with researchers at Leeds University to further elucidate the role of CM-101&#8217;s target, CCL24, in the vascular damage
                associated with systemic sclerosis (SSc).</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z6aa3b42559bd4871aacadfeca29b1b5e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In November, announced that experienced biotechnology executive Donald Marvin joined as chief financial officer, executive vice president and chief operating officer.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z82257e16357d44d0a75b186e771a1cf3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In December, received approval from the FDA for first U.S. Investigational New Drug application&#160; aimed at expanding clinical activities in Phase 2 trial in primary
                sclerosing cholangitis.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z1606766d1edb44e7a8fbeea64703ee0b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In December, biotechnology executive and medical and clinical trial expert David Weiner, MD, joined as interim chief medical officer.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In January 2022, the company announced the addition of Jack Lawler, who brings extensive experience managing global clinical trials, as
        vice president of global clinical development operations. In February 2022, in a planned move approved by the company&#8217;s shareholders, CEO Dale Pfost assumed the additional role of Chairman.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Revisions to Chemomab Clinical Programs</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Chemomab also announced today that following a comprehensive strategic review it is making revisions to its current clinical programs.
        The changes are designed to optimize the clinical development of lead product candidate CM-101 by maximizing the clinical information obtained, generating additional important data to support future advancement to registration trials, and
        decreasing the overall risk in the CM-101 clinical development program in the lead indications of PSC and SSc, as well as potentially in additional indications where the scientific rationale is strong. The key top-line changes to the clinical
        development programs include the following:</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Expanding the company&#8217;s commitment to
          primary sclerosing cholangitis with an enlarged clinical trial that adds an important dose finding component</font>. The company plans to implement a dose finding component to the CM-101 development program by significantly expanding its Phase 2
        trial for PSC. The company will be increasing the size of the study by adding additional dose cohorts, including plans to evaluate both a lower and a higher dose level of CM-101 to support future potential registrational trials. In addition, the
        company plans to add an open-label extension to the trial to evaluate the safety, tolerability and durability of effect over longer treatment durations. Chemomab plans to perform an interim analysis of the currently enrolling dose cohort in the
        study to assess safety and biomarker data, with an expected read-out in the second half of this year.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Focusing Chemomab&#8217;s clinical efforts in
          systemic sclerosis on establishing earlier biological and clinical proof of concept</font>. Chemomab plans to focus its SSc trial towards establishing biological and clinical proof of concept in this patient population. The company is revising
        the design of its planned SSc trial in a way that should enable an expedited path to proof of concept data, as well as further elucidation of the different mechanisms of action of CM-101 in treating the skin, lung and vascular damage seen in SSc
        patients. The company is currently working with key systemic sclerosis researchers and clinical experts to refine and finalize the design and study endpoints of the Phase 2 trial and anticipates that these activities will result in trial initiation
        in the second half of 2022.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Winding down enrollment in the company&#8217;s
          safety, pharmacokinetic and biomarker liver fibrosis study, yielding a data readout targeted near the end of 2022. </font>The company will be winding down its ongoing safety, tolerability and biomarker trial that is evaluating the subcutaneous
        formulation of CM-101 in liver fibrosis patients. Chemomab believes the early completion of this study should be sufficient to achieve its key objectives&#8212;exploring safety and providing the pharmacokinetic data needed to assess next steps in the
        development of the subcutaneous formulation&#8212;while allowing the company to focus its resources on its lead indications of PSC and SSc. The company will be halting screening and enrollment in the coming weeks and anticipates results near the end of
        2022. The data readouts in this study will include safety and tolerability data to support future development of, and deeper insights into CM-101&#8217;s mechanism of action and are expected to provide additional data on the anti-inflammatory and
        antifibrotic activity of CM-101 in liver disease.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The company expects that the proposed changes to the CM-101 development program will provide important data on the clinical dose response
        relationship to inform the broader development program and to identify the optimal dose to advance in later PSC trials. The modifications are also expected to generate proof of concept data on clinically relevant aspects of SSc, a complex
        rheumatological disorder, to best inform the development path for a novel, first-in-class therapeutic like CM-101, along with relevant safety and tolerability data to support the evaluation of higher doses and inform decisions on next steps in the
        development of the subcutaneous formulation.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Chemomab intends to provide more detailed information on these clinical program changes around the time of its first quarter 2022
        conference call in May.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;2021 was a transformational year for Chemomab as we became a public company, launched two Phase 2 trials and expanded our management
        team to include highly experienced biotech executives from the U.S.,&#8221; said Dale Pfost, PhD, CEO<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font>of Chemomab. &#8220;With this foundation in place, we conducted a
        comprehensive review of our clinical programs, which recommended significant changes designed to achieve biological and pharmacological validation for CM-101 sooner and to prepare us to advance to registrational trials in as capital and
        time-efficient a manner as possible<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">. </font>Overall, we believe that these changes will sharpen our focus on our clinical efforts in PSC and SSC, and
        accelerate the timelines, particularly in SSc, to achieve meaningful mechanistic, biological and clinical proof of concept data.&#160;These revisions are expected to provide more clinical data read-outs over the next 24 months&#8212;we anticipate 3-4 data
        readouts compared to the two previously planned. They are also expected to decrease our capital requirements and enable us to extend our cash runway by about six months through to the end of 2023. We are excited about moving forward with this
        revised clinical program and look forward to providing more detail on our plans in the next few months.&#8221;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Fourth Quarter and Full-Year 2021 Financial Highlights</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z56fc29689f1b47d3a907e80ca6967698" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Cash Position:&#160;</font>Cash, cash equivalents and short-term bank
                deposits were $61.2 million as of December 31, 2021, compared to $11.8 million&#160;as of December 31, 2020.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z9938b2412c6e4fc99ff10e6e4e682e45" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Research and Development (R&amp;D) Expenses:&#160;</font>R&amp;D expenses
                were $2.4 million for the quarter and $6.3 million for the full year ended December 31, 2021, compared to $1.3 million and $4.7 million for the same quarter and&#160; year in 2020.&#160;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="z5b62b1311c1743b7ab7c1e21d1b88c2b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">General and Administrative (G&amp;A) Expenses</font>:&#160;G&amp;A expenses
                were $2.6 million for the quarter and $6.0 million for the full year ended December 31, 2021, compared to $0.7 million and $1.3 million for the same quarter and year in 2020.&#160;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" id="zad814c9e8af14b9c877636f117f9cf0a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#9726;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Net Loss</font>:&#160;Net loss was $5.0 million, or a net loss of $0.02 per
                basic and diluted Ordinary Share, for the fourth quarter and $12.5 million, or a net loss of $0.06 per basic and diluted Ordinary Share for the year ended December 31, 2021, compared to $2.0 million, or a net loss of $0.01 per basic and
                diluted share, for the quarter and $6.0 million, or a net loss of $0.04 per basic and diluted Ordinary Share, for the full year ended December 31, 2020.&#160; The weighted average number of Ordinary Shares outstanding, basic and diluted were
                207,468,650 and 136,755,498 for the year ended December 31, 2021, and December 31, 2020, respectively<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">For further details on the company&#8217;s financial results for the year ended December 31, 2021, please refer to the company&#8217;s Annual
        Report on Form 10-K, which will be filed with the SEC before the end of March 2022.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Conference Call</div>
      <div style="line-height: 1.25;">
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Chemomab management will host a conference call for investors&#160;today, Wednesday, March 9, 2022, beginning at&#160;8:00 a.m. Eastern Time&#160;to
          discuss these results and answer questions. Shareholders and other interested parties may participate in the conference call by clicking this <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Webcast link</u></font>
          to access the live webcast or replay, or by dialing 877-407-9208 (in the U.S.) or 201-493-6784 (outside the U.S. and in Israel) and entering passcode 13727097. The live webcast will also be available on the company&#8217;s website at <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>https://investors.chemomab.com/events</u><u>.</u></font></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">A replay of the call will be available for 90 days at <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>www.chemomab.com</u></font>.</div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">About Chemomab Therapeutics</div>
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Chemomab is a clinical-stage biotechnology company focusing
          on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need. Based on the unique and pivotal role of the soluble protein CCL24 in promoting fibrosis and inflammation, Chemomab developed
          CM-101, a monoclonal antibody designed to bind and block CCL24 activity. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is currently in two Phase 2 safety and efficacy
          trials&#8212;one in patients with primary sclerosing cholangitis and the second in patients with liver fibrosis, with a third Phase 2 trial in systemic sclerosis expected to begin in 2022. </font>For more information on Chemomab, visit&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>www.chemomab.com</u></font>.</div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Forward Looking Statements</div>
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. These
        forward-looking statements include, among other things, statements regarding the clinical development pathway for CM-101; the future operations of Chemomab and its ability to successfully initiate and complete clinical trials and achieve regulatory
        milestones; the nature, strategy and focus of Chemomab; the development and commercial potential and potential benefits of any product candidates of Chemomab; and that the product candidates have the potential to address high unmet needs of
        patients with serious fibrosis-related diseases and conditions. Any statements contained in this communication that are not statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements are based
        upon Chemomab&#8217;s current expectations. Forward-looking statements involve risks and uncertainties. Because such statements deal with future events and are based on Chemomab&#8217;s current expectations, they are subject to various risks and uncertainties
        and actual results, performance or achievements of Chemomab could differ materially from those described in or implied by the statements in this presentation, including: risks related to Chemomab&#8217;s ability to effectively implement the revised
        clinical strategy and its ability to achieve the anticipated results; risks related to the projections and associated benefits in pursuing the contemplated changes to the clinical strategy; risks associated with the ongoing transitions of certain
        of our executive officers, including Chemomab&#8217;s new Chief Executive Officer; the uncertain and time-consuming regulatory approval process; risks related to Chemomab&#8217;s ability to correctly manage its operating expenses and its expenses; Chemomab&#8217;s
        plans to develop and commercialize its product candidates, focusing on&#160; CM-101; the timing of initiation of Chemomab&#8217;s planned clinical trials; the timing of the availability of data from Chemomab&#8217;s clinical trials including any potential delays
        associated with Chemomab&#8217;s contemplated revised clinical strategy; the timing of any planned investigational new drug application or new drug application; Chemomab&#8217;s plans to research, develop and commercialize its current and future product
        candidates; the clinical utility, potential benefits and market acceptance of Chemomab&#8217;s product candidates; Chemomab&#8217;s commercialization, marketing and manufacturing capabilities and strategy; Chemomab&#8217;s ability to protect its intellectual
        property position; and the requirement for additional capital to continue to advance these product candidates, which may not be available on favorable terms or at all. Additional risks and uncertainties relating to Chemomab&#8217;s and its business can
        be found under the caption &#8220;Risk Factors&#8221; and elsewhere in Chemomab&#8217;s filings and reports with the SEC. Chemomab expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements
        contained herein to reflect any change in Chemomab&#8217;s expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based, except to the extent required by applicable law.</div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Contacts:</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Investor Relations:</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
          </font>Irina Koffler<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
          </font>LifeSci Advisors, LLC<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
          </font>Phone: +1-917-734-7387<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
          <u>ir@chemomab.com</u></font></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Chemomab Therapeutics:</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
          </font>Barbara Lindheim<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
          Consulting Vice President</font></div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Investor &amp; Public Relations,</div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Strategic Communications</div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Phone: +1-917-355-9234</div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><u>barbara@chemomab.com </u></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <br>
      <div style="line-height: 1.25;">
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Consolidated Balance Sheets as of
          <hr align="center" style="height: 1px; width: 100%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In USD thousands (except share and per share amounts)</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z83963b0ba8524a77aa9d43b5a534c824" class="cfttable">

          <tr>
            <td valign="bottom" style="vertical-align: top; padding-left: 9pt;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">December 31,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">December 31,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; padding-left: 9pt; padding-bottom: 2px;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"> 2021</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2020</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Assets</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Current assets</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Cash and cash equivalents</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">14,686</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">11,674</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Short-term bank deposit</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">46,475</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">24</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Other receivables and prepaid expenses</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">1,527</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">141</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Total current assets</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">62,688</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">11,839</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Non-current assets</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Long-term deposits</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Long-term prepaid expenses</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">908</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Restricted cash</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">55</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">53</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Property and equipment, net</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">357</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">152</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Operating lease right-of-use assets</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">345</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">428</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Total non-current assets</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">1,665</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">637</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Total assets</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">64,353</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">12,476</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Current liabilities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Trade payables</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">1,336</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">93</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Accrued expenses</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">555</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">715</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Employee and related expenses</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">653</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">438</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Operating lease liabilities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">106</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">70</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Total current liabilities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2,650</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,316</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;" colspan="1">
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Non-current liabilities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Non-current<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">&#160;</font>operating
                lease liabilities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">237</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">358</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;" colspan="1" rowspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell" rowspan="1">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell" rowspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell" rowspan="1">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell" rowspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell" rowspan="1">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell" rowspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell" rowspan="1">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Total non-current liabilities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">237</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">358</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Commitments and contingent liabilities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Total liabilities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2,887</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,674</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Shareholders' equity</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%;" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Ordinary shares no par value - Authorized: 650,000,000 shares as of December 31, 2021 and 500,000,000 shares as of December 31,
                2020;</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Issued and outstanding: 228,090,300 ordinary shares at December 31, 2021 and 9,274,838 ordinary shares at December 31, 2020</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%;" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Additional paid-in capital</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">97,639</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">34,497</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Accumulated deficit</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(36,173</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">)</div>
              </div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(23,695</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
              </div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Total shareholders&#8217; equity</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">61,466</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">10,802</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;" colspan="1">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Total liabilities and shareholders&#8217; equity</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">64,353</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">12,476</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Consolidated Statements of Operations
          <hr align="center" style="height: 1px; width: 100%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In USD thousands (except share and per share amounts)</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="zfacfd4faa6c84d87ba89f320b1048705" class="cfttable">

          <tr>
            <td valign="bottom" style="vertical-align: top;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Three months</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Three months</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Year</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Year</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Ended</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Ended</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Ended</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Ended</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">December 31</font>,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">December 31</font>,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">December 31</font>,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">
              <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">December 31</font>,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"> 2021</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2020</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2021</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="line-height: 1.25;">
                <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2020</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Operating expenses</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: top;" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Research and development</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2,383</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,254</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">6,334</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4,684</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">General and administrative</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2,641</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">688</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">6,033</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,288</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Total operating expenses</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">5,024</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,942</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">12,367</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">5,972</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Financing income, net</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">12</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">9</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">111</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(21</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Net loss for the period</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">5,036</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,951</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">12,478</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">5,951</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>

      </table>
      <div style="text-align: left; line-height: 1.25;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="zcaca08c64f7046fcbb812ba0b7fd2958" class="cfttable">

          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Basic and diluted loss per Ordinary Share*</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">0.022</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">0.014</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">0.060</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">0.044</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="za2022fdcb7cf4cba922e6ada91d51311" class="cfttable">

          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Weighted average number of Ordinary Shares outstanding, basic, and diluted*</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">228,018,874</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">143,861,509</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">207,468,650</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">136,755,498</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">*Number of shares has been retroactively adjusted to reflect the share reverse split effected on March 16,&#160;&#160; 2021</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
    <br>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cmmb-20220309.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<xs:schema targetNamespace="http://chemomab.com/20220309" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:cmmb="http://chemomab.com/20220309" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20220309_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20220309_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20220309_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://chemomab.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xs:element name="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" id="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="OrdinarySharesNoParValuePerShareMember" id="cmmb_OrdinarySharesNoParValuePerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>cmmb-20220309_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://chemomab.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="cmmb-20220309.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://chemomab.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="definition: EntityListingsLineItems to DocumentType" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="definition: EntityListingsLineItems to AmendmentFlag" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="definition: EntityListingsLineItems to DocumentPeriodEndDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="definition: EntityListingsLineItems to EntityRegistrantName" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="definition: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="definition: EntityListingsLineItems to EntityFileNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="definition: EntityListingsLineItems to EntityTaxIdentificationNumber" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine2" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine3" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="definition: EntityListingsLineItems to EntityAddressCityOrTown" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="definition: EntityListingsLineItems to EntityAddressStateOrProvince" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="definition: EntityListingsLineItems to EntityAddressCountry" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="definition: EntityListingsLineItems to EntityAddressPostalZipCode" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="definition: EntityListingsLineItems to CityAreaCode" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="definition: EntityListingsLineItems to LocalPhoneNumber" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="definition: EntityListingsLineItems to WrittenCommunications" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="definition: EntityListingsLineItems to SolicitingMaterial" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementTenderOffer" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="definition: EntityListingsLineItems to NoTradingSymbolFlag" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="definition: EntityListingsLineItems to EntityEmergingGrowthCompany" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityExTransitionPeriod" xlink:title="definition: EntityListingsLineItems to EntityExTransitionPeriod" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalYearFocus" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="definition: EntityListingsLineItems to EntityCentralIndexKey" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="definition: EntityListingsLineItems to Security12bTitle" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="definition: EntityListingsLineItems to TradingSymbol" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="definition: EntityListingsLineItems to SecurityExchangeName" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EntityListingsLineItems" xlink:to="EntityListingsTable" xlink:title="definition: EntityListingsLineItems to EntityListingsTable" order="30.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: EntityListingsTable to StatementClassOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20220309.xsd#cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:label="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="definition: ClassOfStockDomain to AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20220309.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="OrdinarySharesNoParValuePerShareMember" xlink:title="OrdinarySharesNoParValuePerShareMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="OrdinarySharesNoParValuePerShareMember" xlink:title="definition: ClassOfStockDomain to OrdinarySharesNoParValuePerShareMember" order="2.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cmmb-20220309_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockDomain_lbl">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis_lbl">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:label xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US" id="dei_EntityExTransitionPeriod_lbl">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:title="label: EntityExTransitionPeriod to dei_EntityExTransitionPeriod_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsTable_lbl" xml:lang="en-US" id="dei_EntityListingsTable_lbl">Entity Listings [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsTable" xlink:to="dei_EntityListingsTable_lbl" xlink:title="label: EntityListingsTable to dei_EntityListingsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsLineItems_lbl" xml:lang="en-US" id="dei_EntityListingsLineItems_lbl">Entity Listings [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsLineItems" xlink:to="dei_EntityListingsLineItems_lbl" xlink:title="label: EntityListingsLineItems to dei_EntityListingsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20220309.xsd#cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:label="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" />
    <link:label xlink:type="resource" xlink:label="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" xml:lang="en-US" id="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:to="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" xlink:title="label: AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember to cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20220309.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="OrdinarySharesNoParValuePerShareMember" xlink:title="OrdinarySharesNoParValuePerShareMember" />
    <link:label xlink:type="resource" xlink:label="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" xml:lang="en-US" id="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1">Ordinary shares, no par value per share [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrdinarySharesNoParValuePerShareMember" xlink:to="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" xlink:title="label: OrdinarySharesNoParValuePerShareMember to cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cmmb-20220309_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://chemomab.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="cmmb-20220309.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://chemomab.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20220309.xsd#cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:label="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="presentation: ClassOfStockDomain to AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20220309.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="OrdinarySharesNoParValuePerShareMember" xlink:title="OrdinarySharesNoParValuePerShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="OrdinarySharesNoParValuePerShareMember" xlink:title="presentation: ClassOfStockDomain to OrdinarySharesNoParValuePerShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: EntityListingsTable to StatementClassOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="presentation: EntityListingsLineItems to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="presentation: EntityListingsLineItems to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: EntityListingsLineItems to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="presentation: EntityListingsLineItems to EntityRegistrantName" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="presentation: EntityListingsLineItems to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: EntityListingsLineItems to EntityTaxIdentificationNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine1" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine2" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine3" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: EntityListingsLineItems to EntityAddressCityOrTown" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: EntityListingsLineItems to EntityAddressStateOrProvince" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="presentation: EntityListingsLineItems to EntityAddressCountry" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: EntityListingsLineItems to EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="presentation: EntityListingsLineItems to CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="presentation: EntityListingsLineItems to LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="presentation: EntityListingsLineItems to WrittenCommunications" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="presentation: EntityListingsLineItems to SolicitingMaterial" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementTenderOffer" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: EntityListingsLineItems to NoTradingSymbolFlag" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: EntityListingsLineItems to EntityEmergingGrowthCompany" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityExTransitionPeriod" xlink:title="presentation: EntityListingsLineItems to EntityExTransitionPeriod" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalYearFocus" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="presentation: EntityListingsLineItems to EntityCentralIndexKey" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="presentation: EntityListingsLineItems to Security12bTitle" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="presentation: EntityListingsLineItems to TradingSymbol" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="presentation: EntityListingsLineItems to SecurityExchangeName" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="EntityListingsLineItems" xlink:title="presentation: EntityListingsTable to EntityListingsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityListingsTable" xlink:title="presentation: CoverAbstract to EntityListingsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ V #8  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #M T8# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%4IM7TRW?9/J
M-I$WH\ZJ?U-36][:W8S;7,,PZYCD#?RJG"25VM!71/1114C"BBB@ HHHH **
M*\]\7^.7AEDT[2),,IVRW(['N%_Q_+UKHPV&J8B?) F4U%79UFK>)=*T7Y;R
MZ42XR(D^9_R'3\:Y.Z^*$88BTTQF'9I9<?H ?YUYRS,[EW8LS')).234UM9W
M5XQ6UMIIV'411EC^E?1TLGP].-ZFOX(YG6D]CME^*%WGYM-@(]!(16K8_$O3
M9V"WEK-:Y_B4^8H^N,']*X!_#NM1IN;2KP+[0L?Z5FLK(Q5U*L.H(P15O+<%
M55HK[F+VLUN?0%G?6NH6XGM+B.:(_P 2-G_]1JQ7@>F:K>Z1=BYLIVC<=1_"
MP]".XKV#PQXCA\16#2JGEW$1"S1YR 3T(]C@_E7B8[+9X9<\7>/Y>IO3JJ6G
M4W****\PU"BBB@ HHHH **** "BBB@ JIJ6J6.CV+WNHW<-K;)]Z25L#Z>Y]
MAS6-XT\::?X*T8WMY^]GD)6WME;#2M_0#N>WU(%?+OBCQ;J_B[4C>:I<EP"?
M*@7B.(>BC^O4]ZZ:&&E5U>B,JE50TZGL/B'X^V-N[0^']->[(X%Q<DQI]0H^
M8CZ[:X*^^-'C6\<F/4(+13_!;VR8_-@Q_6L7PMX!\0^+WW:;9XM@<-=3'9$/
MQ[GV ->J:7^SY8K&IU?6[B60]5M$5 /Q;=G\A78UAJ.CW^\Q3JSV/-Q\5O'
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MO^PG)_Z*BKU6O*O@#_R(E]_V$Y/_ $5%7JM<^(_BR-*?P(*RO$__ "*>L_\
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M_$'C &"YF6VL,Y%I;Y"G_>/5OQX]A6M\-OAQ/XB=]9U.%DT>W5F0.,?:7 X
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M)Y);MIPT.< %$7'('/RFNRHHJ92<I<S&DDK(*I:O9OJ.BW]C&RJ]S;R0JS=
M64@$_G5VBI3L,^>?^&?O$'_06TS\Y/\ XFO>=(LWT[1;"QD96>VMXX69>A*J
M 2/RJ[16M2O.I\1$81CL%%%%9%F%XE\'Z)XMM!!JUFLC*,1S)\LD?^ZW]#Q[
M5X]K?P U*%VDT/5(+F/J(KH&-Q[9&03^5>_45M3KU*?PLB5.,MSY8D^#GCI)
M"JZ*L@'1ENX<'\W!JU8_!+QI=N!/;6MD.[3W*MC_ +XW5].T5M]>J>1'L(GE
M/A?X&:-I4D=UK=PVJ3KR(=NR$'W'5OQ('J*]0DMU^Q/;0JL:^68T4# 48P!C
MTJ:BN:=2<W>3-(Q45H?//_#/WB#_ *"VF?G)_P#$U[KH&GR:3X<TO39G5Y+2
MTB@=DZ,40*2/;BM&BKJ5YU%:0HTXQV"O'O'WPCU?Q9XNN=8M-0L8894C4)+O
MW#:H!Z CM7L-%33J2IN\1RBI*S.$^&7@6]\$Z9J%K?W-M<&YE5QY.<  8P<@
M5A^+_@AI>L327NA3KIER^2T!7,#'V Y3\,CVKU>BFJ]13YT]1>SC:Q\M7WP:
M\;6;D)ID=T@_C@N$(/X,0?TJ.U^#_CBY?!T<0KG!>:XC 'X;L_I7U316_P!>
MJ6V1G[")XCX;^ 2I*D_B34ED4')M;/.&]BY /X ?C7LFG:;9:1816.GVL5M:
MQ#"1QK@#_$^_>K5%85*TZGQ,UC",=@HHHK(H**** "BBB@ KS'XGQ,-4L93]
MUH"H^H;G^8KTZN6\>:,VJZ"985+7%H3(H Y9?XA_7\*[LMJJEB8REMM]YG55
MX,\?HHHK[0X0HHHH *4 L<*"2>@%;'AKP_-XAU+R%)C@0;II<?='H/<U[!I>
MB:?H\ BLK9(^,%\9=OJ>M>;C<RIX9\MKR[&L*3GJ>%RVMQ"NZ6"6-?5T(J*O
MH>2-)HVCE171AAE89!'N*\Z\1?#N4SO<Z+L*,<FV9L%3_LD\8]C6&%SBG5ER
MU%R_D5.@UJM3SVMKPE!)<>*M.6,9*S!S[!>3_*IH?!/B&:79_9[)SRSNH _7
M^5>B>%/"<7AZ)II76:]D7#N!PH_NK_C6V.Q]&G2:C)-M=":=.3EJ=+1117R!
MVA7QUXULIM/\;ZW;3J5=;V5N>ZLQ93^((/XU]BUYU\2?A?#XSVZA8S1VNK1I
MLW.#LF4= V.01V//IZ8ZL+55.?O;,RK0<EH?,5%=I-\)_&\-SY']A2.2<!TE
MC*G\=W'XXKT3X??!>?3]1AU?Q,8B\+!X;)&WC<.A<]#CT&1ZGM7HSQ%.,;W.
M:-.3=K'J7A2RFTWPAHUE<9\^"RACD!/1@@!'X'BMBBBO%;N[G<M$%%%%( HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6UC:QVMI!%!;Q#:D42!54>P'2NBMC%*/+#J9PHM.[)J***\XZ0HHHH ****
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'HHHK(H__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm139763618798456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 09, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  09,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Chemomab Therapeutics Ltd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Kiryat Atidim, Building 7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel Aviv<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">6158002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">77-331-0156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001534248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember', window );">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CMMB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember', window );">Ordinary shares, no par value per share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, no par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>zk2227450_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cmmb="http://chemomab.com/20220309"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cmmb-20220309.xsd" xlink:type="simple"/>
    <context id="c20220309to20220309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2022-03-09</startDate>
            <endDate>2022-03-09</endDate>
        </period>
    </context>
    <context id="c20220309to20220309_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-09</startDate>
            <endDate>2022-03-09</endDate>
        </period>
    </context>
    <context id="c20220309to20220309_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-09</startDate>
            <endDate>2022-03-09</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20220309to20220309"
      id="Fact_c4648d413a80429490b83737684960a3">false</dei:AmendmentFlag>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20220309to20220309"
      id="Fact_827b499388894d2983d2699b4fac3458">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityCentralIndexKey
      contextRef="c20220309to20220309"
      id="Fact_bb5eac91d82c47d694f161e9a8eda0ed">0001534248</dei:EntityCentralIndexKey>
    <dei:SecurityExchangeName
      contextRef="c20220309to20220309_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"
      id="Fact_7800ee96276548b596341b580ba682e4">NASDAQ</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="c20220309to20220309_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"
      id="Fact_6d5d9dde38ce41a79ef18960f5e679b6">NASDAQ</dei:SecurityExchangeName>
    <dei:DocumentType
      contextRef="c20220309to20220309"
      id="Fact_1e8d67a5e319479a96041d8c4f7e3915">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20220309to20220309"
      id="Fact_097c3bd6996d46e2bd4575c8433d9ffd">2022-03-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20220309to20220309"
      id="Fact_54f7699f403b4b8da0f3061dbb621ab8">Chemomab Therapeutics Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20220309to20220309"
      id="Fact_ed7f83e55f0a4b08beddae26671ea988">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20220309to20220309"
      id="Fact_23f534d54203453daaea000a94b759db">001-38807</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20220309to20220309"
      id="Fact_e24b9d3f80794d4685c212a8f19bc425">Kiryat Atidim, Building 7</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20220309to20220309"
      id="Fact_4fa2b9620e824a57b1f54dd90922a682">Tel Aviv</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="c20220309to20220309"
      id="Fact_b9d79dd8c8ac402da729318d023d8bec">IL</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="c20220309to20220309"
      id="Fact_7d3c117f227b4ad7b829a6bd78c06980">6158002</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20220309to20220309"
      id="Fact_056db533a90749b29f8b400205334538">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20220309to20220309"
      id="Fact_a465d30b3ba54a55af9eec32f997a7b4">77-331-0156</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20220309to20220309"
      id="Fact_58591e2e1f2443529562a6b7d3838234">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20220309to20220309"
      id="Fact_34813f63dc0844ef81c013044741f24c">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20220309to20220309"
      id="Fact_c93b00f1407c48d2abcfa1faa8eb2967">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20220309to20220309"
      id="Fact_ee53ffb1d4404dd9bf8384d2237b75eb">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20220309to20220309_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"
      id="Fact_b123c56576e3485d98bde4754511ff63">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20220309to20220309_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"
      id="Fact_efc8b1a62843452ea835025b22e31abb">CMMB</dei:TradingSymbol>
    <dei:Security12bTitle
      contextRef="c20220309to20220309_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"
      id="Fact_adcba5d2ba7c41fa96ede1c9ee9b9160">Ordinary shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20220309to20220309_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"
      id="Fact_e57ed6f5b2144c9b95a26c319b8d02b2">N/A</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20220309to20220309"
      id="Fact_dd30d57e27ef4063b7ff9d2b9c5d7da4">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="c20220309to20220309"
      id="Fact_4060debb196f400b9b60e23eaa2c782f">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MX>@4')WS@C'G2DB;#R&!K*J,"ZZ49T&_^=.G3S5I<%F@7:*"QS1XXAM(!,6
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M&2P7; .XOY;2O)[83V/%E\WAWU!+ P04    " "H,&E4GZ ;\+$"  #B#
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M#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
M   ( *@P:50<.&7J/P$  #P"   /    >&PO=V]R:V)O;VLN>&ULC5'+;L)
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MPNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " "H,&E4!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M *@P:53Y@IY+[0   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( *@P:5297)PC$ 8  )PG   3
M  "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ J#!I5+$A
M99C3!   Y10  !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( *@P:52?H!OPL0(  .(,   -
M  "  14-  !X;"]S='EL97,N>&UL4$L! A0#%     @ J#!I5)>*NQS
M$P(   L              ( !\0\  %]R96QS+RYR96QS4$L! A0#%     @
MJ#!I5!PX9>H_ 0  / (   \              ( !VA   'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( *@P:50D'INBK0   /@!   :              "
M 482  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( *@P
M:51ED'F2&0$  ,\#   3              "  2L3  !;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@     )  D /@(  '44      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>118</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="zk2227450.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://chemomab.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="zk2227450.htm">zk2227450.htm</File>
    <File>cmmb-20220309.xsd</File>
    <File>cmmb-20220309_def.xml</File>
    <File>cmmb-20220309_lab.xml</File>
    <File>cmmb-20220309_pre.xml</File>
    <File>exhibit_99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "zk2227450.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "cmmb-20220309_def.xml"
     ]
    },
    "inline": {
     "local": [
      "zk2227450.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cmmb-20220309_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cmmb-20220309_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cmmb-20220309.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 36,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 5
   },
   "keyCustom": 0,
   "keyStandard": 118,
   "memberCustom": 2,
   "memberStandard": 0,
   "nsprefix": "cmmb",
   "nsuri": "http://chemomab.com/20220309",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227450.htm",
      "contextRef": "c20220309to20220309",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://chemomab.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "zk2227450.htm",
      "contextRef": "c20220309to20220309",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share [Member]"
       }
      }
     },
     "localname": "AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember",
     "nsuri": "http://chemomab.com/20220309",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_OrdinarySharesNoParValuePerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares, no par value per share [Member]"
       }
      }
     },
     "localname": "OrdinarySharesNoParValuePerShareMember",
     "nsuri": "http://chemomab.com/20220309",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityListingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Listings [Line Items]"
       }
      }
     },
     "localname": "EntityListingsLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container for exchange listing information for an entity",
        "label": "Entity Listings [Table]"
       }
      }
     },
     "localname": "EntityListingsTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001178913-22-001006-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-22-001006-xbrl.zip
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ME\E3J:I05</_4BP[Q^9_XJMKPLLDO/P!4$L#!!0    ( *@P:52N&ZL5-@<
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M:S P6/'72\7^2TO%:F>;!L/_BO.N%RHI4PTB9:%(R0,XTF,69$!_5QV[Y$G
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M$B 08"TR)X@SX4XCL*XN%F!D26GPP75"WRJ. )T$\X+4C2]%(O'7JZD7P*L
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M"M##>@[+$H20(&)S@ _ ,P5'X-_!X-UX&H.MP'R>90L0.IAH 5M'A<W-YW.
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M72%A'--D9.[8-=<78J[0J@FD (01U!%".-9BU+Q,5!/*I:P((&>!WBQ@V/+
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M-O#+TAY@?;%DU"25-K>/UB?^3*DQA>.@J$^I980M(O+F<8 IW(HBRS%-0GN
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M-[V#UZ[Z%AP7NU!/&K]SEE/*U#-^ 87!V3_!^ M%LHT'?@A\<>X& -&7V)\
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M%^=.* ZL!'PS$]N7&O#KB@7ZP[TJ"W^\C&VY+80&!0T*K04%*G<8[%>G.(T
M&@$T FRZ8,,>[5>[&(T*&A4T*CQIR8FV"VX,SA2?X# '-BE_N6]4I'/ZRJGN
MNTS<5W1KAL."\6+VX^N.V:'O:OKT73WMD9I@?;"*A-^9]*>BOFEBA"OP7G?^
M[7*7FV-W:/LCTQ[ZKN.,>Y;#36?D>]9D,*[3ER;3:2"AG.HS36S]B:>!*]\]
M&H1Y)CP9SYJ+A'U,8(EYLF#G4YZ(_]39KCHA8F<)$>:1:>GL5BT_6GX>+#\]
MW9=%RX^6GR<+4X!(#4TM4EJDM$@]5"79ST$E/<!QO\9-OTN(9M\\>&Z!8>][
MKC-R?=MU^,2RQ)![?-+S!KU^;XG0VH-ODJ,_Z&[@N'.8%;\0# 3: ?<]]E<\
M^)3%>99FX.O#NALP/_#\C;KKKUU\K0]VIP\L:VR8O;$Q'CT'K:"E2$O11C(J
M[+XQ'O:,@:D+6K44:2EZNI=:FB/#'HZ-X4 [_5JPM& ]4#WUA\9H,##L26."
MSX%)T4Y=_VW[H?_Y6^EWIM+=G/*4.4)$+!%9$G,77Z =+ACW_LQ3=%BS&'[Q
M0^%F5#M!5\$16+04OLW#(&/"]^%G.#>.V*\\<:>L-S0DM>7?S#)7:Z4W3LZ;
M4V1>31.F^-45$0!9R9\RR><8V#<2C2D_\A5Q3@@L6?Z>Q7-XR.J/Y=--S#LI
MXBP^_6GBZ?*G.BO(X9VP&4\N@JB+G'',>)[%Y:%$/H6. >%J%%GZK#)(BF.O
M?G1B;T$?IMDLA __ U!+ P04    " "H,&E4SO1$3M 4  !<D   #0   'IK
M,C(R-S0U,"YH=&WM75ESXSB2?M^(_0\8==2,:]:4>!_R$>&27=7>*A]KNV<Z
MYJ4#($")4Q2I)BG;FE^_"8"42!V6;$NV7&5'1Q=)7(E$9N++Q*']7MZ/T'T_
MBK/V/4FC\*#1R_-!N]6ZN[MK\B_-).VV=%4U6F&<Y3CV6:/('X7Q]P>R\V2"
MLW'V^YG\=X;(K7F>UQ*IXZQ9."\C5*NU?C_[=NWW6!\KT_3PYNFD8)4:NR43
MRZQAEIBZYCS469EC7.!^45Z-,P:(9[]_NOHVR9[/SS_)VLI3'&=!DO9Q'B8Q
MK\E25%W1[4HE2L;\6D7PWNPFMTOK<15#*^L99DH7X\&XG@!G1!!3)$ 175-4
MK5*$LBD^ENU"@L@^KCM/%S+1:T%JF=%/AG&>CN;76B36:O:':<IB?U&)(K56
M),:AG\W/+Y)JF;/0GY\5$NH9\T&Z(">DU+*R>[\W/RM/J=>:YK,# A_G#4:>
M*OEHP++YG(;D%D_F)55>LL+#?I^,"W&E2?J8-/VDS_/JJJ%Z1<[%:LGM0^/P
MO_\+H?T>PU0\P7,>YA$[W&_)?XN/?U$4]"WT69PQBO*DC?ZE?$5?HH3@2.80
M?\>)/^RS.$=^RG ..8=9&'?1R?&7HZL@!+'N9NCRZ@(>&7*;6E-MJI72G60P
M2L-N+T= GX44Q'N"/J4)IFE(NPPI2DE.G^48\7XI[,]A>'O0Z"1Q#@TK-\"M
M!O+EVT$C9_=Y2_03M:#L?JOH*#R2A(Y0EH\B=M ((+\2X'X8C=KH;S=AGV7H
MG-VA*V!J_+==)+[LHHRE8;"'1.XL_ ]K(TT=Y'N(MZ+@*.S&;12Q +[X292D
M;?2+*O[V$,'^]VX*JD"5,BD0?WM\ /9I>(M">M XOK[\''+-_S6DE,6-DCX:
M9H,( VUQ$C,HLA_>MWE/6"H?16[Q"!G.80C2T$<Q[O.B+&P?P9A0/BZ?(]QM
MB)8^8S__PS=MTZ6F9F!7-77/]%3B&H[AV*[IV2HV"D;>YU<L.&CXI6#ER43$
MI'$Z:(!!:Y,DB1B. QS!S' H_MEOU6A:3.))#.(VNL'WI]"3/ Q"7Y@\R$A8
M6B'9U1UB>I[ANJYG4MUS#:K;GD?, /N&:;G+23Y409/DWR.IZP!E*8Y.8\KN
MO[)1A2I"+(9]3Z.N[IL.M3TST&R->=AE%*N,KD05&'?#U$UW9:JN&9A*H.L$
M#!".N^P<4BI$.:ZJ,N;9NF-;IDLLSS9,C5BN2K#MZLQ<2M0?USDH,9>;3H2S
M["*XSA/_^]%]F/UQD=(PQNGHNH=3EITGESC]!XZ&[)*EXM,9$^-V>'YT?7ST
M?^OJD4TMZH&H&Z[/3 T['@LT%R0UL)CM>,1^3H^.!"TX/F:#) OS<=].L-^[
M8@-XXG(9=V_NX-^1KCZ3 ZVZVJ8L8'S28]GA/D=+[4S@(.@'$NBIW4M%E\#H
M*V5GFO<9")9,YI/$02,+^X,(5&^_5:]#-E=M0[QFR3 5;P(=M@O>"7;/%=$B
M'Q/*4+Z%A;ZR%(GVV%Q,TSG]6A?QZ<*'Y:=Z[0/@5D++-\"$:7X,(WC(B5)4
M0U&]LMPD;4PF79"U3"G?RT9:-3ZLR)97$*G-CD/!3M;E?9*O%!J['T2A'^:2
M!D1A0HPS,- 'C0)IMA?RH7'(Q;:]&6[LM^82.![,<3]^//'ZL<7EAQ_^5MT&
MMRJ0K@5X4(!40+K\<3\;X'A%K"JAZ@*DVCA$^RU>V6P;!;#NI64[)$F!F )R
M(OFFD"3/DS[4-KA'61*%%)$(H.TX/4\&;61.)_881_6"AOL)-BX \ /8N :L
MP??(6;J'^CCMAK'"<78;X6&>C#^ELA7Q3>)]T27>NX*/)(7/U:Z+#(,J:R6G
MEC&V:%%T5[@ Q8>2/S-N04$]:",Y1+^=G]Z<'*/KFZ.;D^O]%@&2!H<+R3$W
M3,[U2>>WJ].;TY-K='1^C$Y^[_QZ=/[E!'4NSLY.KZ]/+\Z7DKAICOWSZ/K7
MT_,O-Q?GN^BXV6F"9VB9WDN1U3C\ZR^:K>[)_[_J6'V^N#I#"^%SZ7Y+)W@,
MFS7F4MO!%C,TSW0\#(C9!%?%-P.'&9YFK>"=N,K760C[LMQ_50$$#;DZ.;]!
M5R>7%U<WKZX/E\,T&^(X1WF"P&?BGK)DDF:@)$6:M4,_OCJ128#R'D.%3Q="
M,Z5;AX[\'$&RYAGF3R5&'!CPC@/>3=(<[93O# ,T8%F.V"V/GJ4BF=&/[>6Z
M?BG@Q8D$'16E5SW'-PBU/<^FILUT0DW+L7S7- SJ!<$*(8E:;(=RM 8%>A2/
M1D NBQN'9SCU>\C;%7&ZK38/]H;'=4G@Z(IUPXS'\O.I@(8%)AA&*#!5@YC$
MI5@-#-76*"&VKF&R2C2K4X1^T4V/I7C AGGH9^A;3ILS(R+0SR3>^NH&8N?D
M'I@@N"65HN02PAFZ'C"?NQ@4A3$ZS3/4 =0/1==HUP1YB&/2N4*48Q(Q(#B*
M #'[X)D>--2&>!]@2LMW"7S%XPP9K9AK4(2FB!G'DZ\E-7<AS7N\A/IA#*0!
M"4=XD %P+Y\J:%[!]-_#+"^QN?R>IRSW>_P;;W.O41GI2HQ=/._G8Y1_RU(0
M&!R5XP,C62LZ*;Z?T[)00;!A?)@/T9_CHL@/=X7'0)*( CW"6>0RLD313F,_
M2<%VBMBQ*-21RT^=A%;UCE$G< UF68&*3:*ZA%&*F6[;CL:PYZZ@=U7CR%?R
MVHQV<3I(D]MBP8L;R-,LQ2R:M8PYW3H.+V'LYS!B,[%XW0@LPZ26"2PQ+8-B
MS+"JJM@SB6-YE*P4]=84PW559YFQD@9K&QE7]<VY)"CAO2(CN^W55BP.7>"!
M[=B.8Y3.^2J=%XK<RM/9C\_4[K6SK3(FTNX7ZIRB"P"(*?I?P(<9#06,E=9]
M^3AOGLA.TN^'6;95-)U>7:.3_B!*1CST-8>JMRL48-QKUOOCUG"=VSXDC=_V
M$%5?)D7G27,^;7,$HGSBR^$"X[Q#J6=!J16G)$M=,"7-T\=G"4MC3L#X<=/]
M$:4IR[+BGV]AS+0J>M)-XE$C@&D;9C33=BU?UW3L!II'?%-?)9[T-4Q'.$='
M>4C#_B[Z- PC+@9H%@<\8D9<POMI/DL?Y;FL+J7]$8;X*<9C[4*"*JQ9Q8<M
M9*$#CQ?I37(75P0"H(Q./%M7F:N;V'*(%E@FI9[JZ3K?:[""0-RP"!W=AK?3
MX[];YY7@U&J$2AA>W:3A4<>CU/5=[)NJ3K&C>X;F4E4W*'@ _A- ?X'U.0D/
MX?VGSQF;D-DGCOQEDN4X^E<XF/*E'&KXFN8$.L>YF#K$U3UL$^JXOFI[KKK"
MX-N:Y:KJ; AICM*788LWKVX[!5NY5SM(P]@/!S"]L7OF#_/PECN[,+FS[%F(
MXT6D9P=$ G&9V&8 LH9Z%X:Q)G&KO_[BZIJSET'6B UZ@"A0+'#C+H(!CH9B
MBL,IPZ 2%!CZ/PLUCYO9(\@XI6NJ95-B&0;V5,?TB.X%+C%!<U3X!A[X*O%"
MSYG1,V4A&=\2D)Y+WI$9YQ^;MD4-E1@$6V#S+1QXC/F&'GB>@\$2K$"*XRB&
MP3?$6O;FHL>O*!@[GV&Z /]6!CA3,7O *Y:*#S(1(+D> DH,\L%0A+,R^/]R
M8<ZUU-OI,?^[6.[!@T&:@$'C'CY)[A%A47+'N\H3.4,D":[R%<D=P2C,0#MR
M%E.QLQA8T1]&.8Y9,LRB$<K P<F"D2A>%$@(\%KZ/<4:4SH)'0^A'N!Q/"K3
M @#]R1TOQZ-S(7?HL_86!9#?DJNSCJBQ]6'>ANEG^CN+#-@_TS 'T>*QG&%<
M.,M9=0'&M3R-Z4P+=-,T+-VS;$"L!#"-:[BZL8(5F\&$?!<TP2!S.8@_EXM[
MW=:X9*PUP.E-LY$/;1B,GLO)@F'0[2K'T*"RX'PUC)B4=O#U"GV;6NCEZ[L[
MFH,ZGZ^0;JA-R/CQ=6)5ZY"N!2[>DI;7-"!/\"^WBGF+]WHG8L,>F,$SF"M@
MPH@J>FF8KF8$MD%]U35-%KB:KVJ&:IJ.R57U*;[:AO5R T,_X1#,-Y)%"Q11
M,[&BZ15=K.VT&&NBJ39ESG=E?%?&FC)>IHS/D?QT@-A QM%8>A$$-<CO>P91
MU4 S5<<W7:ICX@=8"S!V&;@BMO-3*"5P2O$KK%IMIM1,JN@[Y*-\6TE/98%W
M37W7U(<T]33+ABR=KZ^,6480$(V:ILK#L20 4&M273<<XEALA?7YGU=?#::8
M._XC]+4HL)*^;C8 -C\>\<*QCXHS()USEH)[/UBX;W5B' NW'1C<?M_JM4FG
MO8@&K^JWF]Z"]<N[7I@SA3..<9+N4OS<6/G481-]?)XD[9(==1?Q_SY*.;OA
MA]3E%EJ_AWQ^EFC5B'DY%IO8*52(3;4+CYH1"]IT<Q/$/8:]*>;]F+\2@]#U
MJ$^2:&?U58JWP//IR,I+\_R\V \K)'H1YUDQ$2U*+PTK**??DX\3._RVE]"$
M(7K4IH;R6+FF$V$OJHO"FF[XEFTY-C-,UZ*>2R@S'<NT-"T([.57(+S"^=^R
M7C2I&,DRNU)HTDKE*!>UHQU=_8B2H@64%=GC!-0F1;>\&33@AT%YPB;@W$NL
M26H+!.-IGLC&!5E8]T<)<F&.I=FM(OW =XF&;=TU#=/2&78-2]4MHNO,T#!9
MCO1?08H[9V>?W@7M903-6B1HRS8O+[UQ V:KC.(_40</0#8B=(;3[RQ?US[F
MK>+BPGEGO:/^,\OI(H/XSN%-6X*WOHUQK: 04Y]@B^H$.[ZI!=BS&66:[S'F
M$0_X]!(W)UV\0[4M$J\U0C7+8=0. )MIINF#/%E8MWU#\PC?B4J6[Y5=QZU<
MK:.G'$I[EY$-H:RE-[4]B++^_OHAY\UM+/L[.D]RO@R!<JE0>RB)HQ$_% QZ
M$LL8,HQ WJMM!"LWARUVE9MO9W/=:4SY<@5#9(1\L=$.\GQ'=STFCL]-;8 +
M,P3]!0/!J^FB;IK< 7/\I#_@F^)PAB@+PEB>JZYLY5$M-'MAP^2>!@/M\(Q.
M<0F*V-13%H$6_1X>\,/9?)MC915%)XI>5#L1Q2470DPUQ-=6)M54FGI# W@R
M?S!D<\O.,Y2%OXBR'5FT,J%0:J@4)A7=88&IV@9Q@L #[.+Y%G4H7ML6-GUV
ME>_-#,!I\(!.\,W9<Q4LG-E<V@/U81$8'5"?.!'+6,.,B5S X&(+*[^S.10&
M2%[]):P7;RL:\<:%K>*J& /YD)*RVY!?J@M*B6,_K-ZGBWUQP(27XM=A4YS2
M3.YBI0\NIAD[N+Z85M6SYHIB=W\S[HB\8Z1ZX$>U5<H(T3P;9$XE'K%5IAL,
M8]UW7#W8X,KR6#;JUW@5MWRM[Z*T.I"><VN:;+-LS(\83@7\Z=5OQ=#F78LA
MVY#+5?+6WTO<99]2AK_S7?^3);EJ$P/(HA">1\%!SJ]FP]$='F4+*JJNZ\U<
MZZ84F$5>R#9+N[S$3:36EBS+F]STZD5N#UQR7"0U9JY=FWK[BZ(4]T)S^N5A
M@RN6L?P#/'_0/RCH U(^3.Y_KK#E><-<6V!9/+S/:^21Z\SKN92Z-FY+;ZA>
MSQE7V=@J&VCJ[)TECU^!KXSO#6SJUE*,OHP?\Y#Y*3A22&^J>A.!M VC7!S'
MN@"[7>P. :.+/I>&&742F"AX0K.4E%J'G@?#*^R8[7Q-F9?DG+WG9^J^P^GW
M)[4\.V3B"TREC,_3NMLTK,$F!K)Q>!&CVM53NVCQ)4AHA\]__&"6KNYU2MP%
M;]K>1X#*V1 F4HP&XB1>"E,[AND<QS$8,5^<30&)F#,Q(\@KQ87/[2)3,DQA
M7O]S*"XI$G+#K\E"$A,<,U]>A&IH@F2MB8Y  P?C0RIU @#E!L,T#K,>E(4>
M,8D9.%[NA23,D><U-=%&.+XRH<@)H!Y S/BJY^;T8"\9[@D$^\%D!@0#F#7^
M*0V!3[!P@PJN26[*(TQ^@0RY!+""Y> SEF(T'IM"D$39K ?@18!"PL#% JQ)
MQ_EA6BOS5F6(RPZ .'!,F; [=1#GSO''YOE+NUPP<%\*6E7:JYE+D=_EB#/A
M;N,=@$Z4#<F_H5&.('G!*,0DC&13HG&< T<%4;NSG:S)7E7HD&#GJ#RNM?"$
M2!)4N<&=S&I?!*G3X'67HW& P5%Q<I8WTV4Q*'U4H8</< 1%AH E.#'9$(R%
MI&87R!&%V;W0.1%*J/<CDS>/^?4.5>K8=J5ZP;G3:ZI:98(<AR;ES%F8JVQ=
M#'NECHOVVHA'WD(?>KY#/XZ[MBE1>,Z.Q&?'71^&C%,[EM:"&[6FL_B&CNW$
MCN5<+)V5E0#A PQH:O86,V!:;)_82]=I:N86=_/!<3YFF9^& WE)V=/0_YK4
M8BO\*? S,)*_2E) I#\\3]&:O;S?..3X=+^%#S>C%;+_SSQ NT@6MY^YEU.^
M@O!AR&B:9/[W@%]$!=R9NL)WQ1'[X45;4\U-BNZK]V^CUGQ+^MA)@##$PXGH
ME*_\8E_<JW.,<XS$E7X[W"6GW&OB[G7A^YV*'U]$_#?8$"VNV/[XEJ,]+Q*F
M?FB RU-!T]5(W"3K>4S<_E%S>'%"IH;CRU,S\PEJ'"I(1\K<@/]L1Y\1DQ=5
M;5U<?K$(+?CUE*4#_T(P[?KTR_G1S6]7)S^;<]ZH_1J$7+#\<QBFA1^^:A!I
MSDHG'48CY..A^,E/OO0NKR;BS1"&,N@4)"0QCW]6Q9JP'HX"'DGA=8KH3Y&7
MA]J&,107->-AWDM2Z C=6$#E1U]O,;VF]4/ZC< M;G\/&GICNLM:T]WB'L^U
M39U?3\XNSHX^H9M?3ZZ.+D]^NSGM7*-O-\>KK2,] ,&:]C;[TX\:_C4X%8O4
MH1]2&K$WQH\'+K=O&O-&_4?KI=LT?X+!7*#";[*7&U3AK7 JYQIW_KM+[>E
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?,C<T-3 N:'1M4$L%!@     &  8 @0$  )!?      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
